TTY Biopharm Co (4105.TWO) Stock Price
TTY Biopharm Co Price
Over the last 19 years TTY Biopharm Co grew revenue by 5.5% annually, reaching 6.45 B TWD. Earnings per share have grown at 12.4% per year over the last 19 years. For TTY Biopharm Co, the net margin of 24.2% is up versus 18.3% a few years ago. At today's price the dividend yield works out to roughly 5.22%. The payout ratio is around 67% of earnings. The dividend has grown at 11.9% per year over the past 3 years. The consensus 12-month price target for TTY Biopharm Co is 94.86 TWD, about 17.8% above where the stock trades today. Of 11 analysts, 8 rate the stock a buy — an overall Buy consensus.
TTY Biopharm Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
TTY Biopharm Co business model & stock analysis
Frequently asked questions about TTY Biopharm Co
Analysts currently set an average price target of 94.86 TWD for the TTY Biopharm Co stock (median: 94.86 TWD), implying +17.7 % versus the latest price. The consensus is based on 11 analyst ratings.
9 analysts currently rate the TTY Biopharm Co stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect TTY Biopharm Co to generate revenue of 7.03 B TWD and earnings per share of 7.27 TWD.
Converted at the current exchange rate, the TTY Biopharm Co share trades at 2.23 EUR (80.50 TWD).
The expected revenue of TTY Biopharm Co is 7.03 B TWD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of TTY Biopharm Co is 1.81 B TWD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of TTY Biopharm Co is currently 11.07. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the TTY Biopharm Co stock.
The price-to-sales ratio (P/S) of TTY Biopharm Co is currently 2.85. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the TTY Biopharm Co stock.
The Eulerpool Quality Score for TTY Biopharm Co is 7/10.
The ISIN of TTY Biopharm Co is TW0004105002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of TTY Biopharm Co is 4105.TWO. The ticker symbol is used to trade TTY Biopharm Co shares on the stock exchange.
TTY Biopharm Co stock
TTY Biopharm Co Peer Group
TTY Biopharm Co FIGI
All fundamentals and in-depth analysis of TTY Biopharm Co
Our stock analysis for TTY Biopharm Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TTY Biopharm Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.